Ann: Change in substantial holding, page-3

Nice find SS. Have found the DMX monthly reports. Will look out for Perennial's reports.

I tend to agree with their assessment, the September quarterly could have / should have been crafted better.

Whilst the revenue growth was below expectations it wasn't negative or worse than last year.

I can appreciate disclosure obligations but the language, tone and word selection seemed to project negativity.

This is not to say, they gild the lily in reporting, but they use verbage that compliments the numbers.

If a 4C was just a spreadsheet, the data did not represent a ~40% drop in market cap.

PVM are loyal supporters of MedAdvisor and this is really encouraging to see from a retail perspective.

The strategic options may have been announced to steady the ship.

It appears to have worked, share price is buoyant/stable, but it also suggests no news until the next 4C or after.

Interesting parties to work with, AE Partners have HQ in Adelaide and HWL their long term Counsel.

AE share floor space in Morgans (I'm ex ADL but now MEL).

Like you, I'm not sure what the objectives are:

• board structure
• registry review
• takeover defence
• M&A
• do nothing

With presence in 95% of pharmacies in AU, MedAdvisor certainly isn't a bit player.

They're valued across all - community pharmacy, chain brands and independents.

I suspect PVM will hoover up and dip/hold the price below 30c for the time being.

There's certainly value at these levels.